Tirzepatide 101: The Complete Beginner's Guide

What is Tirzepatide?

Tirzepatide is a once-weekly injectable medication for weight loss and Type 2 diabetes. It's sold as Zepbound (for weight loss) and Mounjaro (for diabetes) by Eli Lilly.

What makes tirzepatide different: it's a "dual agonist" that mimics two hormones (GLP-1 and GIP) instead of just one. This dual action produces stronger appetite suppression and more weight loss than GLP-1-only medications like semaglutide.

Brand names Zepbound (weight loss), Mounjaro (diabetes)
Manufacturer Eli Lilly
Dosing Once weekly injection
Mechanism GLP-1 + GIP dual receptor agonist
FDA approval 2022 (diabetes), 2023 (weight loss)

How Does It Work?

Tirzepatide activates two hormone receptors that regulate appetite and metabolism:

GLP-1 (Glucagon-like Peptide-1): The same pathway targeted by semaglutide. Reduces hunger signals in the brain, slows digestion, and helps regulate blood sugar.

GIP (Glucose-dependent Insulinotropic Polypeptide): The second hormone. Enhances the effects of GLP-1, may improve how your body handles fat, and could reduce nausea compared to GLP-1-only drugs.

Together, these create what some researchers call a "metabolic reset"—more powerful appetite suppression, better blood sugar control, and improved body composition.

The "food noise" effect: Many patients report tirzepatide completely silences the constant mental chatter about food. Not just reduced hunger, but a fundamental shift in how food occupies your thoughts.

How Effective Is It?

The SURMOUNT clinical trials established tirzepatide as the most effective weight loss medication available:

For perspective: someone starting at 250 lbs could expect to lose around 50 lbs on tirzepatide. Results that previously required bariatric surgery are now achievable with a weekly injection.

The Dosing Schedule

Tirzepatide uses a gradual titration over 5-6 months. You start low and increase monthly:

Month 1: 2.5mg

Initiation dose. Not expected to produce significant weight loss—just letting your body adjust.

Month 2: 5mg

First therapeutic dose. Many patients start noticing appetite changes here.

Month 3: 7.5mg

Intermediate dose. Some patients achieve great results here and stay.

Month 4: 10mg

Common maintenance dose. Many patients find this their "sweet spot."

Month 5: 12.5mg

Higher dose for those who need more.

Month 6: 15mg

Maximum dose. Not everyone needs to go this high.

Key difference from semaglutide: Tirzepatide offers more "parking spots." Many patients get excellent results at 5mg, 7.5mg, or 10mg without ever reaching the maximum dose. If side effects are tough at one level, you can step back and still see benefits.

Side Effects

Similar to other GLP-1 medications, tirzepatide's most common side effects are gastrointestinal:

Interestingly, some patients report tirzepatide causes less nausea than semaglutide. The GIP receptor activation may actually have an anti-nausea effect. Your experience may vary.

Serious risks (rare but important): pancreatitis, gallbladder problems, thyroid tumors (in rodent studies). Not for use if you have personal/family history of medullary thyroid cancer or MEN2 syndrome.

Who Should Consider Tirzepatide?

Cost

Brand-name (Zepbound): ~$1,059/month retail without insurance

Compounded tirzepatide: $250-400/month through telehealth

Tirzepatide costs more than semaglutide in both brand and compounded forms. For many, the extra cost is worth the extra results—but semaglutide at half the price still produces significant weight loss.

How to Get Started

Tirzepatide is available through telehealth providers as a compounded medication or, less commonly, through insurance as brand-name Zepbound. The process:

  1. Complete an online health assessment
  2. Consult with a licensed provider
  3. Get approved and choose your medication
  4. Receive shipment (cold-chain shipping)
  5. Begin at 2.5mg, titrate up monthly

Compare providers offering tirzepatide

See All Providers →